Biological mechanisms of chronic fatigue (Q37834153)

24 August 2017

1 reference

title

Biological mechanisms of chronic fatigue (English)

1 reference

24 August 2017

Katrine B Norheim

1

1 reference

24 August 2017

Grete Jonsson

series ordinal

2

1 reference

24 August 2017

Roald Omdal

series ordinal

3

1 reference

24 August 2017

publication date

1 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

50

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

1009-1018

1 reference

Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

A review of health related quality of life in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Fatigue in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Feelings of fatigue and psychopathology: a conceptual history

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Tired, weak, or in need of rest: fatigue among general practice attenders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Behavioral symptoms in patients with breast cancer and survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Inflammatory biomarkers for persistent fatigue in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Is fatigue an independent and persistent symptom in patients with Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Fatigue and basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Outcomes in rheumatoid arthritis: incorporating the patient perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

New insights into the experience of fatigue among patients with rheumatoid arthritis: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6-month course of TNF inhibitors: prospective intervention study and partial economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Primary Sjogren's syndrome: too dry and too tired

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Predictors of subjective fatigue among individuals with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

The prevalence and associations of fatigue in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Multiple sclerosis-associated fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

The relationship of sleep disturbances and fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Biological basis of the behavior of sick animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Interleukin-1 receptor antagonist: role in biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Brain-immune communication pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Phase 1 Trial of Recombinant Human Interleukin-1β (rhIL-1β), Carboplatin, and Etoposide in Patients with Solid Cancers: Southwest Oncology Group Study 8940

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Fatigue and proinflammatory cytokine activity in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Fatigue in primary Sjögren's syndrome--a link to sickness behaviour in animals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Rationale for interleukin-6 blockade in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Interleukin-1-induced interleukin-6 synthesis is mediated by the neutral sphingomyelinase/Src kinase pathway in neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

The Pathophysiologic Roles of Interleukin-6 in Human Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

IL-6 transsignaling: the in vivo consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Anti-CD20 treatment in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Interleukin-1 beta stimulates cell proliferation in the intermediate lobe of the rat pituitary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

The neuroendocrinology of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

The neuroendocrine axis in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Redefining oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Protein carbonylation, cellular dysfunction, and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Mitochondrial complex I: structure, function and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Molecular insights into quorum sensing in Acidithiobacillus ferrooxidans bacteria via molecular modelling of the transcriptional regulator AfeR and of the binding mode of long-chain acyl homoserine lactones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Gene expression profile exploration of a large dataset on chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Development of a fatigue scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

The Parkinson fatigue scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/RHEUMATOLOGY/KEQ454

10.1093/RHEUMATOLOGY/KEQ454

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference